NCT00003816 2021-08-13Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic CancerRoswell Park Cancer InstitutePhase 2/3 Completed361 enrolled 16 charts
NCT00582933 2016-02-01Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated DonorMemorial Sloan Kettering Cancer CenterPhase 2 Completed96 enrolled 5 charts
NCT00083551 2015-11-23UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation ChemotherapyUniversity of ArkansasPhase 3 Completed668 enrolled 7 charts
NCT00793650 2012-08-30Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding StudyEmory UniversityPhase 1/2 Terminated39 enrolled 9 charts
NCT00135135 2008-06-03Therapy for Children With NeuroblastomaSt. Jude Children's Research HospitalPhase 2 Completed23 enrolled